The online consultation is now closed. The content found on this page is a snapshot of the live consultation as it was presented to the public and contains the content that was open for submissions during the consultation period.
The purpose of this letter is to provide an opportunity for comment on the proposed addition of four medicinal ingredients to Part I of Schedule F to the Food and Drug Regulations.
This consultation is open for comment starting February 1, 2010 until April 19, 2010. Please select and read through the link below titled "consultation document". Once read please submit your comments via email, fax or by mail to:
Refer to Project Number 1621
Bureau of Policy, Science and International Programs
1600 Scott Street, Holland Cross, Tower "B", Second Floor
Address Locator: 3102C5
Ottawa, Ontario
K1A 0K9
Telephone: (613) 948-4623
Fax: (613) 941-6458
Interested parties are encouraged to provide comments and suggestions by April 19, 2010.
Health Canada will make the results of this consultation available on this Web site.
If you have any questions, contact us at Regulatory Affairs.